BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 2649184)

  • 1. Limits of phenotypic markers for the diagnosis of megakaryoblastic leukemia.
    Breton-Gorius J; Villeval JL; Kieffer N; Mitjavila MT; Guichard J; Vainchenker W
    Blood Cells; 1989; 15(1):259-77. PubMed ID: 2649184
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ultrastructural and cytochemical characterization of blasts from early erythroblastic leukemias.
    Breton-Gorius J; Villeval JL; Mitjavila MT; Vinci G; Guichard J; Rochant H; Flandrin G; Vainchenker W
    Leukemia; 1987 Mar; 1(3):173-81. PubMed ID: 3118105
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of platelet glycoproteins by erythroid blasts in four cases of trisomy 21.
    Debili N; Kieffer N; Mitjavila MT; Villeval JL; Guichard J; Teillet F; Henri A; Clemetson KJ; Vainchenker W; Breton-Gorius J
    Leukemia; 1989 Sep; 3(9):669-78. PubMed ID: 2527326
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glycoprotein I identification during normal and pathological megakaryocytic maturation.
    Breton-Gorius J; Vanhaeke D; Tabilio A; Vainchenker W; Deschamps JF; Xu FS
    Blood Cells; 1983; 9(2):275-91. PubMed ID: 6229299
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Megakaryoblastic crisis of chronic myelogenous leukemia cytological and clinical studies in three cases].
    Ikegami T; Hasegawa Y; Hanada T; Nakazawa M; Abe T
    Rinsho Ketsueki; 1989 Jun; 30(6):898-903. PubMed ID: 2795902
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunological and cytochemical characterization of megakaryocytic lineage leukemia.
    Breton-Gorius J; Vainchenker W
    Prog Clin Biol Res; 1986; 215():301-17. PubMed ID: 3523522
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Properties of a cell line (MEG-01SSF) of human megakaryoblastic leukemia cells.
    Takeuchi M; Satoh M; Ogura M; Saito H; Takeuchi K
    Res Commun Inst Ferment; 1991; (15):22-9. PubMed ID: 1367286
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Usefulness of CD9 detection in the diagnosis of acute megakaryoblastic leukemia.
    Yatomi Y; Yoneyama A; Nakahara K
    Eur J Haematol; 2004 Mar; 72(3):229-30. PubMed ID: 14962244
    [No Abstract]   [Full Text] [Related]  

  • 9. On the quest for lineage specific markers for the diagnosis of megakaryoblastic leukemia.
    Berridge MV; Fraser JK
    Blood Cells; 1989; 15(1):278-83. PubMed ID: 2930850
    [No Abstract]   [Full Text] [Related]  

  • 10. [Diagnosis of acute megakaryoblastic leukemia].
    Koike T; Aoki S; Maruyama S; Shibata A
    Rinsho Ketsueki; 1988 Aug; 29(8):1163-9. PubMed ID: 3204667
    [No Abstract]   [Full Text] [Related]  

  • 11. Physician Education: Myelodysplastic Syndrome.
    Yoshida Y
    Oncologist; 1996; 1(4):284-287. PubMed ID: 10388004
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lineage identification of acute leukemias: relevance of immunologic and ultrastructural techniques.
    Stasi R; Del Poeta G; Venditti A; Bruno A; Suppo G; Aronica G; Di Carlo G; Papa G
    Hematol Pathol; 1995; 9(2):79-94. PubMed ID: 7559258
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Acute leukemia with active hemophagocytosis, positive immunologic markers for the megakaryocyte-platelet lineage, and translocation (16; 21) (p11; q22].
    Shimizu H; Ui T; Kawai S; Kaneko Y; Fujimoto T
    Rinsho Ketsueki; 1990 Jan; 31(1):70-4. PubMed ID: 2313908
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alpha- and beta-synucleins are new diagnostic tools for acute erythroid leukemia and acute megakaryoblastic leukemia.
    Maitta RW; Wolgast LR; Wang Q; Zhang H; Bhattacharyya P; Gong JZ; Sunkara J; Albanese JM; Pizzolo JG; Cannizzaro LA; Ramesh KH; Ratech H
    Am J Hematol; 2011 Feb; 86(2):230-4. PubMed ID: 21264917
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The value of intracellular CD41 antigen detection to the diagnosis of acute megakaryoblastic leukemia].
    Miki J; Koike K; Sawai N; Matsuura H; Kurokawa Y; Sakashita K; Nakazawa T; Ito S; Hidaka E; Koike T; Komiyama A
    Rinsho Ketsueki; 1999 Jul; 40(7):568-73. PubMed ID: 10483140
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phenotypic changes in the megakaryocyte-platelet lineage.
    Stenberg PE
    Scanning Microsc; 1988 Dec; 2(4):2117-27. PubMed ID: 3238385
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Establishment of a human megakaryoblastic cell line (T-33) from chronic myelogenous leukemia in megakaryoblastic crisis.
    Tange T; Nakahara K; Mitani K; Yamasaki I; Yasuda H; Tanaka F; Mizuguchi M; Oda H; Yatomi Y; Takanashi R
    Cancer Res; 1988 Nov; 48(21):6137-44. PubMed ID: 3167860
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of megakaryocytic and erythroid properties in human leukemic cells.
    Tani T; Ylänne J; Virtanen I
    Exp Hematol; 1996 Feb; 24(2):158-68. PubMed ID: 8641337
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Establishment and characterization of a novel human immature megakaryoblastic leukemia cell line, M-MOK, dependent on fibroblasts for its viability.
    Itano M; Tsuchiya S; Minegishi N; Fujie H; Minegishi M; Morita S; Yambe T; Ohashi Y; Masuda T; Koike T
    Exp Hematol; 1995 Nov; 23(12):1301-9. PubMed ID: 7589286
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Leukemia-associated marker combinations in acute leukemia suitable for detection of minimal residual disease.
    Babusíková O; Mesárosová A; Koníková M; Kusenda J; Glasová M; Klobusická M
    Neoplasma; 1993; 40(5):275-81. PubMed ID: 8272155
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.